Capital Flow Monitor · Sponsors · CIK 1501697
X4 Pharmaceuticals, Inc
61 NORTH BEACON STREET, BOSTON, MA, 02134 · 857-529-8300
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$85.0M
Sold
$85.0M
% sold
100.0%
Investors
18
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-25 | D ·current | 506(b) | $85.0M | $85.0M | 100.0% | 18 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Adam Craig — Executive Officer / Director, BOSTON, MA
- John Volpone — Executive Officer, BOSTON, MA
- Christophe Arbet-Engels — Executive Officer, BOSTON, MA
- Mark Baldry — Executive Officer, BOSTON, MA
- Mary DiBiase — Executive Officer, BOSTON, MA
- David Kirske — Executive Officer, BOSTON, MA
- Gary J. Bridger — Director, BOSTON, MA
- Francoise De Craecker — Director, BOSTON, MA
- Murray W. Stewart — Director, BOSTON, MA
- Michael S. Wyzga — Director, BOSTON, MA
Placement agents
- Stifel, Nicolaus & Company Incorporated · 35 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.